Cargando…
Organotypic human ex vivo models for coronavirus disease 2019 research and drug development
Since the discovery of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in late 2019, intense research efforts on an unprecedented scale have focused on the study of viral entry mechanisms and adaptive immunity. While the identification of angiotensin-converting enzyme 2 (ACE2) and other...
Autores principales: | Youhanna, Sonia, Wright, Shane C., Lauschke, Volker M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8075816/ https://www.ncbi.nlm.nih.gov/pubmed/34029832 http://dx.doi.org/10.1016/j.coph.2021.04.006 |
Ejemplares similares
-
Comprehensive Evaluation of Organotypic and Microphysiological Liver Models for Prediction of Drug-Induced Liver Injury
por: Zhou, Yitian, et al.
Publicado: (2019) -
Ex vivo model of epilepsy in organotypic slices—a new tool for drug screening
por: Magalhães, Daniela M., et al.
Publicado: (2018) -
Deep Annotation
of Donated Chemical Probes (DCP) in
Organotypic Human Liver Cultures and Patient-Derived Organoids from
Tumor and Normal Colorectum
por: Tredup, Claudia, et al.
Publicado: (2023) -
In vitro and ex vivo modeling of enteric bacterial infections
por: Taebnia, Nayere, et al.
Publicado: (2022) -
Calcium measurements in enzymatically dissociated or mechanically microdissected mouse primary skeletal muscle fibers
por: Youhanna, Sonia, et al.
Publicado: (2023)